These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10988263)

  • 21. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of regression of cardiac hypertrophy.
    Chevalier B; Callens-el Amrani F; Heymes C; Swynghedauw B
    Am J Cardiol; 1994 Apr; 73(10):10C-17C. PubMed ID: 8166049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
    Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of perindopril on cardiovascular hypertrophy of the SHR: respective roles of reduced blood pressure and reduced angiotensin II levels.
    Black MJ; Campbell JH; Campbell GR
    Am J Cardiol; 1993 Jun; 71(17):17E-21E. PubMed ID: 8328362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of the QT interval duration in hypertension with antihypertensive treatment.
    Klimas J; Kruzliak P; Rabkin SW
    Hypertens Res; 2015 Jul; 38(7):447-54. PubMed ID: 25787045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac transplantation, perindopril, and left ventricular hypertrophy in spontaneously hypertensive rats.
    Harrap SB; O'Sullivan JB
    Hypertension; 1996 Oct; 28(4):622-6. PubMed ID: 8843888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of left ventricular hypertrophy results in improvement of QT dispersion in patients with hypertension.
    Karpanou EA; Vyssoulis GP; Psichogios A; Malakou C; Kyrozi EA; Cokkinos DV; Toutouzas PK
    Am Heart J; 1998 Nov; 136(5):765-8. PubMed ID: 9812069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats.
    Levy BI; Michel JB; Salzmann JL; Azizi M; Poitevin P; Camilleri JP; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S23-5. PubMed ID: 3225686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left ventricular hypertrophy and QT dispersion in hypertension.
    Mayet J; Shahi M; McGrath K; Poulter NR; Sever PS; Foale RA; Thom SA
    Hypertension; 1996 Nov; 28(5):791-6. PubMed ID: 8901825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation of changes in cardiovascular mass and performance with angiotensin-converting enzyme inhibitors in Wistar-Kyoto and spontaneously hypertensive rats.
    Frohlich ED; Sasaki O
    J Am Coll Cardiol; 1990 Nov; 16(6):1492-9. PubMed ID: 2229803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular hypertrophy in hypertensive patients is associated with abnormal rate adaptation of QT interval.
    Singh JP; Johnston J; Sleight P; Bird R; Ryder K; Hart G
    J Am Coll Cardiol; 1997 Mar; 29(4):778-84. PubMed ID: 9091524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative systolic dysfunction in female spontaneously hypertensive rat myocardium.
    Renna BF; MacDonnell SM; Reger PO; Crabbe DL; Houser SR; Libonati JR
    J Appl Physiol (1985); 2007 Jul; 103(1):353-8. PubMed ID: 17431084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
    J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remodeling of heart and arteries by chronic converting enzyme inhibition in spontaneously hypertensive rats.
    Levy BI; Michel JB; Salzmann JL; Devissaguet M; Safar ME
    Am J Hypertens; 1991 Mar; 4(3 Pt 2):240S-245S. PubMed ID: 1828353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antirenin immunization versus angiotensin converting enzyme inhibition in rats.
    Lo M; Julien C; Michel JB; Vincent M; Cerutti C; Gomez-Sanchez CE; Sassard J
    Hypertension; 1990 Jul; 16(1):80-8. PubMed ID: 2194942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multivariate associates of QT interval parameters in diabetic patients with arterial hypertension: importance of left ventricular mass and geometric patterns.
    Salles GF; Cardoso CR; Deccache W
    J Hum Hypertens; 2003 Aug; 17(8):561-7. PubMed ID: 12874614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the QT interval and its adaptation to rate, assessed with continuous electrocardiographic recordings in patients with ventricular fibrillation, as compared to normal individuals without arrhythmias.
    Tavernier R; Jordaens L; Haerynck F; Derycke E; Clement DL
    Eur Heart J; 1997 Jun; 18(6):994-9. PubMed ID: 9183592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of age and dietary sodium on the cardiovascular and renal effects of ramipril in spontaneously hypertensive rats.
    Teräväinen TL; Mervaala EM; Pörsti I; Laakso J; Vapaatalo H; Karppanen H
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):311-21. PubMed ID: 9379779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
    Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.